Hmdb loader
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Identification
HMDB Protein ID HMDBP14520
Secondary Accession Numbers None
Name Beta-arrestin-2
Synonyms
  1. Arrestin beta-2
  2. Non-visual arrestin-3
Gene Name ARRB2
Protein Type Unknown
Biological Properties
General Function Not Available
Specific Function Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. Involved in internalization of P2RY1, P2RY4, P2RY6 and P2RY11 and ATP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 and subsequent recycling or degradation. Involved in ubiquitination of IGF1R. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2) and MAPK10 (JNK3). ERK1/2 and JNK3 activated by the beta-arrestin scaffold are largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Acts as signaling scaffold for the AKT1 pathway. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Increases ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Involved in CCR7-mediated ERK1/2 signaling involving ligand CCL19. Is involved in type-1A angiotensin II receptor/AGTR1-mediated ERK activity. Is involved in type-1A angiotensin II receptor/AGTR1-mediated MAPK10 activity. Is involved in dopamine-stimulated AKT1 activity in the striatum by disrupting the association of AKT1 with its negative regulator PP2A. Involved in AGTR1-mediated chemotaxis. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. Suppresses UV-induced NF-kappa-B-dependent activation by interacting with CHUK. The function is promoted by stimulation of ADRB2 and dephosphorylation of ARRB2. Involved in p53/TP53-mediated apoptosis by regulating MDM2 and reducing the MDM2-mediated degradation of p53/TP53. May serve as nuclear messenger for GPCRs. Upon stimulation of OR1D2, may be involved in regulation of gene expression during the early processes of fertilization. Also involved in regulation of receptors other than GPCRs. Involved in endocytosis of TGFBR2 and TGFBR3 and down-regulates TGF-beta signaling such as NF-kappa-B activation. Involved in endocytosis of low-density lipoprotein receptor/LDLR. Involved in endocytosis of smoothened homolog/Smo, which also requires GRK2. Involved in endocytosis of SLC9A5. Involved in endocytosis of ENG and subsequent TGF-beta-mediated ERK activation and migration of epithelial cells. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN. Involved in insulin resistance by acting as insulin-induced signaling scaffold for SRC, AKT1 and INSR. Involved in regulation of inhibitory signaling of natural killer cells by recruiting PTPN6 and PTPN11 to KIR2DL1. Involved in IL8-mediated granule release in neutrophils. Involved in the internalization of the atypical chemokine receptor ACKR3. Acts as an adapter protein coupling FFAR4 receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis (PubMed:22282525, PubMed:23809162). During the activation step of NLRP3 inflammasome, directly associates with NLRP3 leading to inhibition of proinflammatory cytokine release and inhibition of inflammation (PubMed:23809162).
Pathways
  • Chemical carcinogenesis - receptor activation
  • Chemokine signaling pathway
  • Dopaminergic synapse
  • Endocytosis
  • GnRH secretion
  • Hedgehog signaling pathway
  • MAPK signaling pathway
  • Morphine addiction
  • Olfactory transduction
  • Parathyroid hormone synthesis, secretion and action
  • Relaxin signaling pathway
Reactions Not Available
GO Classification
Biological Process
dopamine receptor signaling pathway
protein deubiquitination
transcription from RNA polymerase II promoter
platelet activation
negative regulation of release of cytochrome c from mitochondria
negative regulation of protein ubiquitination
negative regulation of neuron apoptotic process
cell chemotaxis
membrane organization
protein transport
negative regulation of protein kinase B signaling cascade
regulation of excitatory postsynaptic membrane potential
G-protein coupled receptor signaling pathway
negative regulation of interleukin-1 beta production
receptor internalization
negative regulation of tumor necrosis factor production
positive regulation of DNA biosynthetic process
positive regulation of collagen biosynthetic process
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
positive regulation of ERK1 and ERK2 cascade
G-protein coupled receptor internalization
negative regulation of GTPase activity
negative regulation of protein phosphorylation
positive regulation of peptidyl-tyrosine phosphorylation
adult walking behavior
negative regulation of NF-kappaB transcription factor activity
positive regulation of protein kinase B signaling cascade
brain development
positive regulation of calcium ion transport
desensitization of G protein-coupled receptor signaling pathway by arrestin
follicle-stimulating hormone signaling pathway
negative regulation of natural killer cell mediated cytotoxicity
negative regulation of toll-like receptor signaling pathway
positive regulation of cardiac muscle cell differentiation
negative regulation of smooth muscle cell apoptotic process
positive regulation of epithelial cell apoptotic process
Wnt signaling pathway, planar cell polarity pathway
positive regulation of synaptic transmission, dopaminergic
positive regulation of receptor internalization
negative regulation of interleukin-6 production
transforming growth factor beta receptor signaling pathway
detection of temperature stimulus involved in sensory perception of pain
positive regulation of gene expression
proteasomal ubiquitin-dependent protein catabolic process
positive regulation of peptidyl-serine phosphorylation
negative regulation of interleukin-12 production
protein ubiquitination
Cellular Component
cytosol
cytoplasm
plasma membrane
endocytic vesicle
postsynaptic membrane
nucleus
nucleoplasm
coated pit
basolateral plasma membrane
dendritic spine
cytoplasmic vesicle
postsynaptic density
endosome
Molecular Function
protein-containing complex binding
G protein-coupled receptor binding
ubiquitin protein ligase binding
receptor binding
alpha-1A adrenergic receptor binding
alpha-1B adrenergic receptor binding
14-3-3 protein binding
angiotensin receptor binding
D1 dopamine receptor binding
follicle-stimulating hormone receptor binding
mitogen-activated protein kinase binding
platelet activating factor receptor binding
type 2A serotonin receptor binding
protein domain specific binding
enzyme binding
arrestin family protein binding
protein kinase B binding
identical protein binding
type 1 angiotensin receptor binding
Cellular Location Not Available
Gene Properties
Chromosome Location Not Available
Locus Not Available
SNPs Not Available
Gene Sequence Not Available
Protein Properties
Number of Residues 409
Molecular Weight 46105.36
Theoretical pI 7.69
Pfam Domain Function
Signals Not Available
Transmembrane Regions Not Available
Protein Sequence Not Available
GenBank ID Protein Not Available
UniProtKB/Swiss-Prot ID P32121
UniProtKB/Swiss-Prot Entry Name ARRB2_HUMAN
PDB IDs Not Available
GenBank Gene ID Not Available
GeneCard ID Not Available
GenAtlas ID Not Available
HGNC ID Not Available
References
General References
  1. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [PubMed:14702039 ]
  2. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [PubMed:15489334 ]
  3. Zody MC, Garber M, Adams DJ, Sharpe T, Harrow J, Lupski JR, Nicholson C, Searle SM, Wilming L, Young SK, Abouelleil A, Allen NR, Bi W, Bloom T, Borowsky ML, Bugalter BE, Butler J, Chang JL, Chen CK, Cook A, Corum B, Cuomo CA, de Jong PJ, DeCaprio D, Dewar K, FitzGerald M, Gilbert J, Gibson R, Gnerre S, Goldstein S, Grafham DV, Grocock R, Hafez N, Hagopian DS, Hart E, Norman CH, Humphray S, Jaffe DB, Jones M, Kamal M, Khodiyar VK, LaButti K, Laird G, Lehoczky J, Liu X, Lokyitsang T, Loveland J, Lui A, Macdonald P, Major JE, Matthews L, Mauceli E, McCarroll SA, Mihalev AH, Mudge J, Nguyen C, Nicol R, O'Leary SB, Osoegawa K, Schwartz DC, Shaw-Smith C, Stankiewicz P, Steward C, Swarbreck D, Venkataraman V, Whittaker CA, Yang X, Zimmer AR, Bradley A, Hubbard T, Birren BW, Rogers J, Lander ES, Nusbaum C: DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. Nature. 2006 Apr 20;440(7087):1045-9. [PubMed:16625196 ]
  4. Neuhaus EM, Mashukova A, Barbour J, Wolters D, Hatt H: Novel function of beta-arrestin2 in the nucleus of mature spermatozoa. J Cell Sci. 2006 Aug 1;119(Pt 15):3047-56. Epub 2006 Jul 4. [PubMed:16820410 ]
  5. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Girnita A, Lefkowitz RJ, Larsson O: {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase. J Biol Chem. 2005 Jul 1;280(26):24412-9. Epub 2005 May 3. [PubMed:15878855 ]
  6. Yu MC, Su LL, Zou L, Liu Y, Wu N, Kong L, Zhuang ZH, Sun L, Liu HP, Hu JH, Li D, Strominger JL, Zang JW, Pei G, Ge BX: An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. Nat Immunol. 2008 Aug;9(8):898-907. doi: 10.1038/ni.1635. Epub 2008 Jul 11. [PubMed:18604210 ]
  7. Marion S, Oakley RH, Kim KM, Caron MG, Barak LS: A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors. J Biol Chem. 2006 Feb 3;281(5):2932-8. Epub 2005 Nov 30. [PubMed:16319069 ]
  8. Szabo EZ, Numata M, Lukashova V, Iannuzzi P, Orlowski J: beta-Arrestins bind and decrease cell-surface abundance of the Na+/H+ exchanger NHE5 isoform. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2790-5. Epub 2005 Feb 7. [PubMed:15699339 ]
  9. Huttenrauch F, Pollok-Kopp B, Oppermann M: G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers. J Biol Chem. 2005 Nov 11;280(45):37503-15. Epub 2005 Sep 6. [PubMed:16144840 ]
  10. Cheng ZJ, Zhao J, Sun Y, Hu W, Wu YL, Cen B, Wu GX, Pei G: beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4. J Biol Chem. 2000 Jan 28;275(4):2479-85. [PubMed:10644702 ]
  11. Busillo JM, Armando S, Sengupta R, Meucci O, Bouvier M, Benovic JL: Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J Biol Chem. 2010 Mar 5;285(10):7805-17. doi: 10.1074/jbc.M109.091173. Epub 2010 Jan 4. [PubMed:20048153 ]
  12. Willoughby EA, Collins MK: Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2. J Biol Chem. 2005 Jul 8;280(27):25651-8. Epub 2005 May 10. [PubMed:15888437 ]
  13. Shenoy SK, Modi AS, Shukla AK, Xiao K, Berthouze M, Ahn S, Wilkinson KD, Miller WE, Lefkowitz RJ: Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6650-5. doi: 10.1073/pnas.0901083106. Epub 2009 Apr 10. [PubMed:19363159 ]
  14. Puca L, Chastagner P, Meas-Yedid V, Israel A, Brou C: Alpha-arrestin 1 (ARRDC1) and beta-arrestins cooperate to mediate Notch degradation in mammals. J Cell Sci. 2013 Oct 1;126(Pt 19):4457-68. doi: 10.1242/jcs.130500. Epub 2013 Jul 25. [PubMed:23886940 ]
  15. Oishi A, Karamitri A, Gerbier R, Lahuna O, Ahmad R, Jockers R: Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT2 receptor reciprocally modulate their signaling functions. Sci Rep. 2017 Aug 21;7(1):8990. doi: 10.1038/s41598-017-08996-7. [PubMed:28827538 ]
  16. Chen W, Ren XR, Nelson CD, Barak LS, Chen JK, Beachy PA, de Sauvage F, Lefkowitz RJ: Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science. 2004 Dec 24;306(5705):2257-60. doi: 10.1126/science.1104135. [PubMed:15618519 ]
  17. Rapoport B, Kaufman KD, Chazenbalk GD: Cloning of a member of the arrestin family from a human thyroid cDNA library. Mol Cell Endocrinol. 1992 Apr;84(3):R39-43. doi: 10.1016/0303-7207(92)90038-8. [PubMed:1587386 ]
  18. Barak LS, Ferguson SS, Zhang J, Caron MG: A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem. 1997 Oct 31;272(44):27497-500. doi: 10.1074/jbc.272.44.27497. [PubMed:9346876 ]
  19. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS: Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem. 2000 Jun 2;275(22):17201-10. doi: 10.1074/jbc.M910348199. [PubMed:10748214 ]
  20. Barlic J, Andrews JD, Kelvin AA, Bosinger SE, DeVries ME, Xu L, Dobransky T, Feldman RD, Ferguson SS, Kelvin DJ: Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI. Nat Immunol. 2000 Sep;1(3):227-33. doi: 10.1038/79767. [PubMed:10973280 ]
  21. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG: Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*. J Biol Chem. 2001 Jun 1;276(22):19452-60. doi: 10.1074/jbc.M101450200. Epub 2001 Mar 9. [PubMed:11279203 ]
  22. Kim YM, Barak LS, Caron MG, Benovic JL: Regulation of arrestin-3 phosphorylation by casein kinase II. J Biol Chem. 2002 May 10;277(19):16837-46. doi: 10.1074/jbc.M201379200. Epub 2002 Mar 4. [PubMed:11877451 ]
  23. Wang P, Gao H, Ni Y, Wang B, Wu Y, Ji L, Qin L, Ma L, Pei G: Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J Biol Chem. 2003 Feb 21;278(8):6363-70. doi: 10.1074/jbc.M210350200. Epub 2002 Dec 17. [PubMed:12488444 ]
  24. Ahn S, Nelson CD, Garrison TR, Miller WE, Lefkowitz RJ: Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1740-4. doi: 10.1073/pnas.262789099. Epub 2003 Feb 11. [PubMed:12582207 ]
  25. Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP, Wang XF, Lefkowitz RJ, Blobe GC: Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science. 2003 Sep 5;301(5638):1394-7. doi: 10.1126/science.1083195. [PubMed:12958365 ]
  26. Ahn S, Wei H, Garrison TR, Lefkowitz RJ: Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. J Biol Chem. 2004 Feb 27;279(9):7807-11. doi: 10.1074/jbc.C300443200. Epub 2004 Jan 7. [PubMed:14711824 ]
  27. Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, Struthers RS: Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem. 2004 May 28;279(22):23214-22. doi: 10.1074/jbc.M402125200. Epub 2004 Mar 30. [PubMed:15054093 ]
  28. Gao H, Sun Y, Wu Y, Luan B, Wang Y, Qu B, Pei G: Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol Cell. 2004 May 7;14(3):303-17. doi: 10.1016/s1097-2765(04)00216-3. [PubMed:15125834 ]
  29. Stalheim L, Ding Y, Gullapalli A, Paing MM, Wolfe BL, Morris DR, Trejo J: Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking. Mol Pharmacol. 2005 Jan;67(1):78-87. doi: 10.1124/mol.104.006072. Epub 2004 Oct 8. [PubMed:15475570 ]
  30. Hunton DL, Barnes WG, Kim J, Ren XR, Violin JD, Reiter E, Milligan G, Patel DD, Lefkowitz RJ: Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol Pharmacol. 2005 Apr;67(4):1229-36. doi: 10.1124/mol.104.006270. Epub 2005 Jan 5. [PubMed:15635042 ]
  31. Ren XR, Reiter E, Ahn S, Kim J, Chen W, Lefkowitz RJ: Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1448-53. doi: 10.1073/pnas.0409534102. Epub 2005 Jan 25. [PubMed:15671180 ]
  32. Edeling MA, Mishra SK, Keyel PA, Steinhauser AL, Collins BM, Roth R, Heuser JE, Owen DJ, Traub LM: Molecular switches involving the AP-2 beta2 appendage regulate endocytic cargo selection and clathrin coat assembly. Dev Cell. 2006 Mar;10(3):329-42. doi: 10.1016/j.devcel.2006.01.016. [PubMed:16516836 ]
  33. Gesty-Palmer D, Chen M, Reiter E, Ahn S, Nelson CD, Wang S, Eckhardt AE, Cowan CL, Spurney RF, Luttrell LM, Lefkowitz RJ: Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem. 2006 Apr 21;281(16):10856-64. doi: 10.1074/jbc.M513380200. Epub 2006 Feb 21. [PubMed:16492667 ]
  34. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G: Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol. 2006 Feb;7(2):139-47. doi: 10.1038/ni1294. Epub 2005 Dec 25. [PubMed:16378096 ]
  35. Innamorati G, Piccirillo R, Bagnato P, Palmisano I, Schiaffino MV: The melanosomal/lysosomal protein OA1 has properties of a G protein-coupled receptor. Pigment Cell Res. 2006 Apr;19(2):125-35. doi: 10.1111/j.1600-0749.2006.00292.x. [PubMed:16524428 ]
  36. Lee NY, Blobe GC: The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J Biol Chem. 2007 Jul 20;282(29):21507-17. doi: 10.1074/jbc.M700176200. Epub 2007 May 31. [PubMed:17540773 ]
  37. Zhang X, Wang F, Chen X, Chen Y, Ma L: Post-endocytic fates of delta-opioid receptor are regulated by GRK2-mediated receptor phosphorylation and distinct beta-arrestin isoforms. J Neurochem. 2008 Jul;106(2):781-92. doi: 10.1111/j.1471-4159.2008.05431.x. Epub 2008 Apr 17. [PubMed:18419762 ]
  38. You HJ, How T, Blobe GC: The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2. Carcinogenesis. 2009 Aug;30(8):1281-7. doi: 10.1093/carcin/bgp071. Epub 2009 Mar 26. [PubMed:19325136 ]
  39. Garcia Lopez MA, Aguado Martinez A, Lamaze C, Martinez-A C, Fischer T: Inhibition of dynamin prevents CCL2-mediated endocytosis of CCR2 and activation of ERK1/2. Cell Signal. 2009 Dec;21(12):1748-57. doi: 10.1016/j.cellsig.2009.07.010. Epub 2009 Jul 28. [PubMed:19643177 ]
  40. Li X, MacLeod R, Dunlop AJ, Edwards HV, Advant N, Gibson LC, Devine NM, Brown KM, Adams DR, Houslay MD, Baillie GS: A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex. FEBS Lett. 2009 Oct 20;583(20):3310-6. doi: 10.1016/j.febslet.2009.09.035. Epub 2009 Sep 24. [PubMed:19782076 ]
  41. Cheung R, Malik M, Ravyn V, Tomkowicz B, Ptasznik A, Collman RG: An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages. J Leukoc Biol. 2009 Oct;86(4):833-45. doi: 10.1189/jlb.0908551. Epub 2009 Jul 20. [PubMed:19620252 ]
  42. Yan B, Huo Z, Liu Y, Lin X, Li J, Peng L, Zhao H, Zhou ZN, Liang X, Liu Y, Zhu W, Liang D, Li L, Sun Y, Cui J, Chen YH: Prolyl hydroxylase 2: a novel regulator of beta2 -adrenoceptor internalization. J Cell Mol Med. 2011 Dec;15(12):2712-22. doi: 10.1111/j.1582-4934.2011.01268.x. [PubMed:21255264 ]
  43. Ray P, Mihalko LA, Coggins NL, Moudgil P, Ehrlich A, Luker KE, Luker GD: Carboxy-terminus of CXCR7 regulates receptor localization and function. Int J Biochem Cell Biol. 2012 Apr;44(4):669-78. doi: 10.1016/j.biocel.2012.01.007. Epub 2012 Jan 25. [PubMed:22300987 ]
  44. Watson SJ, Brown AJ, Holliday ND: Differential signaling by splice variants of the human free fatty acid receptor GPR120. Mol Pharmacol. 2012 May;81(5):631-42. doi: 10.1124/mol.111.077388. Epub 2012 Jan 26. [PubMed:22282525 ]
  45. Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, Guarda G, Tian Z, Tschopp J, Zhou R: Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013 Jun 27;38(6):1154-63. doi: 10.1016/j.immuni.2013.05.015. [PubMed:23809162 ]
  46. Watts AO, Verkaar F, van der Lee MM, Timmerman CA, Kuijer M, van Offenbeek J, van Lith LH, Smit MJ, Leurs R, Zaman GJ, Vischer HF: beta-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR. J Biol Chem. 2013 Mar 8;288(10):7169-81. doi: 10.1074/jbc.M112.406108. Epub 2013 Jan 22. [PubMed:23341447 ]